MEPRIMET M1

MEPRIMET M1 Tablet is an oral medication formulated to assist in the management of blood glucose levels in individuals diagnosed with type 2 diabetes mellitus. This pharmaceutical agent works synergistically with a balanced diet and regular physical activity to enhance glycemic control among adults. The mechanism of action involves facilitating the effective utilization of insulin within the body, which in turn contributes to the reduction of elevated blood sugar levels. Adhering to the prescribed dosage and duration as instructed by your healthcare provider is essential for optimal results. It is advisable to ingest the tablet alongside food to minimize potential gastrointestinal discomfort. In cases where a dose is overlooked, it should be taken promptly unless it is near the time for the next scheduled dose; in such instances, the missed dose should be omitted without doubling up. Caution is warranted as excessive dosing can lead to hypoglycemia. Individuals using this medication might experience hypoglycemia, especially when combined with other antidiabetic agents, alcohol consumption, or meal omissions. Regular monitoring of blood glucose is recommended during the treatment course. Other side effects that may be observed include nausea, diarrhea, abdominal pain, headaches, increased risk of bone fractures, and respiratory infections. Prior to initiating treatment, patients are advised to disclose any pre-existing conditions related to kidney, liver, or heart health. Pregnant individuals or those who are breastfeeding should seek medical advice before use. Routine kidney function assessments may be conducted by your healthcare provider while on this treatment.